ASC, Oncology Med Strike Projected $300K Deal

Oncology Med Executes Its Second Contract for Its New Prostate Cancer Brachytherapy Program With a Northeast ASC

PITTSBURGH, PA — Oncology Med, Inc. announces that it has executed its second contract for its new brachytherapy program with an ambulatory surgical center (ASC) located in the Northeast. Brachytherapy is the treatment of prostate cancer through the implantation of radioactive seeds. It is projected that the contract will add $300,000 of revenue over the next 12 months thereby increasing the company’s run rate by 15 percent over that same period.

Dr. William J. Walker, chairman of Oncology Med, Inc., states, "I am extremely pleased with the execution of our second contract for our new prostate cancer brachytherapy program. As we mentioned in our press release dated February 12, 2008, the new rules and changes made to reimbursement policies for ambulatory surgical centers by the Center for Medicare and Medicaid Services will increase the demand for our services to these medical facilities. This second contract is an additional endorsement of the tremendous opportunity available to us and I believe there will be several additional contracts we may enter into in the near future."

Source: Oncology Med, Inc.

Share this article: Email, Slashdot, Digg, Del.icio.us, Yahoo!MyWeb, Windows Live Favorites, Furl
Add this article feed to: RSS, My Yahoo, Newsgator, Bloglines

Read Comments [0]